Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
CA 2113995 C · Owner: Mallinckrodt Inc. · Inventors: De Jong, Martinus T. M.; Miller, Kathleen M.; Deutsch, Edward A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Gentisic acid and its derivatives substantially inhibit peptide autoradiolysis. Gentisic acid or its derivatives may also be used in combination with other stabilizers such as inositol ascorbic acid, and citrate to inhibit autoradiolysis of radiolabeled peptides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 31, 1992 and granted April 22, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 31, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 31, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.